Key Updates
Boeing shares surged 2.72% to $241.22 since the May 12 report, breaking decisively above the $238 Morningstar fair value threshold and establishing a new multi-day high. The advance extends YTD gains to 11.10% and reflects continued momentum from Q1 delivery performance, with Boeing maintaining its competitive advantage over Airbus in Q1 2026 deliveries (143 vs 114 aircraft). The stock has now recovered all losses from the May 12 pullback and trades at a 1.4% premium to analyst fair value, suggesting the operational turnaround narrative is gaining traction with investors despite ongoing cash flow challenges.
Current Trend
Boeing demonstrates strong positive momentum across all timeframes, with the stock advancing 1.84% intraday, 4.91% over five days, 8.59% over one month, and 23.97% over six months. The YTD gain of 11.10% significantly outpaces the broader market recovery and reflects investor confidence in the delivery ramp-up trajectory. The current price of $241.22 represents a technical breakout above the $238-240 resistance zone that has constrained the stock over the past week, with the next resistance level likely near $246 (the previous Morningstar fair value estimate). Support has established at $235, representing the recent consolidation floor. The consistent upward trajectory since mid-April, interrupted only by brief profit-taking sessions, indicates sustained institutional accumulation as delivery metrics improve.
Investment Thesis
The investment thesis centers on Boeing's operational recovery through increased aircraft delivery volumes, particularly for the 737 MAX program which represents approximately 50% of enterprise value. With Q1 2026 deliveries reaching 143 aircraft (up 10% year-over-year) and production operating at approximately 42 units monthly for the 737 MAX, Boeing is executing its path toward positive free cash flow in H2 2026, projected at $1-3 billion annually. The record backlog of $695 billion across all segments ($576 billion in commercial aircraft representing over 6,100 units) provides multi-year revenue visibility and validates market demand for Boeing's product portfolio. The narrow-body market shift favors Boeing's positioning, with low-cost carrier expansion and emerging market growth driving 737 demand. Critical catalysts include FAA approval to increase 737 MAX production to 47 units monthly, certification of the 737 MAX 7 and MAX 10 variants expected in late 2026 with 2027 deliveries, and 777X certification anticipated in late 2026. The defense segment's 21% revenue growth and record $86 billion backlog provides earnings stability while commercial operations recover.
Thesis Status
The investment thesis is strengthening as operational execution aligns with management guidance. Q1 2026 results exceeded expectations with revenue of $22.2 billion (14% growth) and an adjusted loss per share of $0.20 versus consensus estimates of $0.83 loss, demonstrating improved operational leverage. Boeing's delivery performance surpassing Airbus in Q1 2026 marks a continuation of the competitive momentum gained in 2025, validating the turnaround trajectory. However, the thesis faces near-term headwinds from negative free cash flow of $1.5 billion in Q1 and cash decline from $29.4 billion to $20.9 billion due to debt repayments, highlighting the capital-intensive nature of the recovery. The Morningstar analyst's reduction of fair value from $246 to $238 citing slower delivery ramp-up and increased capital requirements tempers enthusiasm, though the stock now trades above this revised target. The thesis remains intact but execution risk persists, particularly regarding production rate increases and certification timelines for new variants.
Key Drivers
Boeing's near-term trajectory depends on four critical factors. First, delivery momentum continuation with Q1 2026's 143 aircraft deliveries establishing competitive superiority over Airbus's supply-chain constrained 114 units. Second, 737 MAX production rate expansion pending FAA approval to increase from 42 to 47 units monthly, which would significantly accelerate cash generation. Third, certification progress for 737 MAX 7 and MAX 10 variants expected in late 2026 with deliveries beginning in 2027, expanding addressable market segments. Fourth, international order momentum exemplified by Biman Bangladesh Airlines' 14-aircraft order, reflecting Boeing's competitive positioning in emerging markets and potential geopolitical trade dynamics favoring U.S. manufacturers.
Technical Analysis
Boeing shares exhibit bullish technical characteristics following the breakout above $238 resistance. The stock has established a rising support trendline connecting lows at $195 (six months ago), $222 (one month ago), and $235 (current week), indicating consistent buying pressure on pullbacks. The 2.72% advance on May 13 occurred on what appears to be above-average volume based on the sustained momentum, suggesting institutional participation rather than retail-driven volatility. The $238-240 zone that acted as resistance throughout early May has now converted to support, with the next technical target at $246 (previous analyst fair value) representing 2% upside. The relative strength across all timeframes (positive returns across 1-day, 5-day, 1-month, 6-month, and YTD periods) indicates strong trend persistence. However, the stock's position 1.4% above the current $238 analyst fair value suggests limited margin of safety, with downside risk to $235 support if profit-taking emerges.
Bull Case
- Record backlog provides multi-year revenue visibility: Boeing's $695 billion total backlog including $576 billion across 6,100 commercial aircraft ensures sustained production and revenue growth through 2030, with Q1 2026 adding 140 net orders demonstrating continued market demand despite competitive pressures. Source
- Delivery momentum establishes competitive advantage: Q1 2026 deliveries of 143 aircraft surpassed Airbus's 114 units, extending Boeing's 2025 victory and positioning the company to capture market share as Airbus faces supply-chain constraints threatening its 870-unit annual target. Source
- Path to positive free cash flow validated: Management reaffirmed H2 2026 positive free cash flow guidance of $1-3 billion annually, with Q1 results beating expectations (adjusted loss of $0.20 vs $0.83 consensus) demonstrating operational leverage as delivery volumes increase toward the 500 annual 737 MAX target. Source
- Production rate expansion approval imminent: Pending FAA approval to increase 737 MAX production from 42 to 47 units monthly would accelerate cash generation significantly, as the 737 program represents approximately 50% of enterprise value and each incremental delivery improves fixed cost absorption. Source
- Certification catalysts unlock new market segments: Expected late 2026 certification of 737 MAX 7, MAX 10, and 777X with 2027 delivery commencement expands addressable market and backlog conversion, while international orders like Biman Bangladesh's 14-aircraft purchase demonstrate global demand recovery in emerging markets. Source and Source
Bear Case
- Cash burn continues despite delivery improvements: Q1 2026 generated negative free cash flow of $1.5 billion with operating cash flow of negative $0.2 billion, while cash and investments declined from $29.4 billion to $20.9 billion due to debt repayments, indicating the recovery remains capital-intensive and financially fragile. Source
- Valuation premium eliminates margin of safety: Morningstar reduced fair value estimate from $246 to $238 citing slower delivery ramp-up and increased long-term capital requirements, with the current $241.22 price trading 1.4% above this revised target, leaving limited upside and significant downside risk if execution falters. Source
- Commercial segment remains unprofitable: Despite 143 Q1 deliveries and $9.2 billion in revenue, the commercial aircraft unit still reported an operational loss, with the company's overall GAAP loss per share of $0.11 and core loss per share of $0.20 demonstrating profitability remains elusive even at improved production rates. Source
- Regulatory and certification risks persist: The 737 MAX 7 and MAX 10 certifications expected in late 2026 with 2027 deliveries have experienced repeated delays, while 777X certification timeline remains uncertain, creating execution risk that could delay backlog conversion and cash flow improvement beyond current projections. Source
- Production rate increases dependent on FAA approval: The critical expansion from 42 to 47 monthly 737 MAX units requires FAA authorization that remains pending, with regulatory scrutiny elevated following historical safety issues, creating uncertainty around the timing and magnitude of production-driven cash flow acceleration. Source